Navigation Links
Waters New Biopharmaceutical System Solution Uniquely Unites UPLC/MS Analyses and Workflows Driven by Industry First Scientific Information System
Date:1/10/2011

MILFORD, Mass., Jan. 10, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today introduced its Waters® Biopharmaceutical System Solution at WCBP, the 15th Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products in Washington, D.C.  The new Biopharmaceutical System brings together UPLC®/MS characterization technology with UNIFI™ Scientific Information System, an industry first comprehensive software solution that uniquely unites all aspects of biotherapeutic analyses and workflows for high-resolution analytics across the development process continuum.

The combination of UltraPerformance Liquid Chromatography®, mass spectrometry, and bioinformatics technologies results in efficient flow of data and information and conforms to biopharmaceutical quality guidelines and regulations.

The Biopharmaceutical System Solution includes:

  • ACQUITY UPLC® H-Class Bio System featuring a bio-inert flow path and quaternary solvent management with Auto-Blend Plus™ Technology, for flexibility in executing high-resolution bioseparations;
  • Waters Peptide and Protein Separation Technology Columns engineered with the selectivity to leverage the characteristics of biomolecules and QC-tested to ensure consistent results;
  • Xevo® G2 Tof Mass Spectrometer, the most sensitive exact-mass quantitative and qualitative benchtop MS system designed with Engineered Simplicity™;
  • UNIFI Scientific Information System, an interactive workflow-driven data platform for flexible instrument control, advanced data processing and mining and comprehensive reporting, with GxP laboratory compatibility that enables routine deployment throughout your organization.

"Waters is now the first company to offer biopharmaceutical scientists a total system for protein characterization using high-end mass spectrometry that supports good manufacturing practices regulations (GMP) that biopharmaceutical companies are required to comply with," said Jeff Mazzeo, Director of Biopharmaceutical Business Operations for Waters Division. "In addition to being able to operate in a GxP compliant environment, the new Biopharmaceutical System allows customers to extract and share the maximum amount of information.  For example, when a scientist develops a peptide map in the discovery laboratory, all of the methods and reports generated can be shared with colleagues down the line in the quality control (QC) laboratory leading to significant productivity gains. UNIFI is the common platform that allows customers to share information in a much more efficient manner than previously possible."

Focused on task-specific workflow design, the Biopharmaceutical System features automated data processing and simplified results validation.  Leveraging UNIFI's architecture, the intuitive user interface can be configured for the roles and capabilities of the scientists throughout an organization.  Critical to biopharmaceutical organizations is reliance on an analytical system that supports GMP and compliance tools, such as electronic signatures and user authentication, all with underlying secure database technology.  Lastly, this Biopharmaceutical System is scalable to use as a workstation with the ability to expand to workgroup and enterprise deployments.

With the scalability and flexibility built into the system, customers can anticipate the following benefits from the Biopharmaceutical System:

  • Implementing proven UPLC, exact-mass Tof MS, and bioinformatics technologies purposely built for biotherapeutic analysis, the system addresses protein characterization needs today and laboratories' growth plans for the future.
  • Streamlining analytics by standardizing workflows across laboratories, and expedite development decisions and regulatory filings with efficient information synthesis is designed to increase productivity.
  • With the versatility to meet the needs of multiple users in a diverse analytical organization, the UNIFI-based platform enables easier transfer of information between departments, so therapeutics can efficiently move from non-regulated investigations to compliant analyses.
  • Because customers ultimately know best how to meet their regulatory compliance requirements; the Biopharmaceutical System provides a configurable tool to enable customers to deploy analytical technologies with the greatest efficiency.

For more information on the Biopharmaceutical Platform, please visit: http://www.waters.com/waters/nav.htm?cid=10195515

About Waters Corporation (www.waters.com)

For more than 50 years, Waters Corporation (NYSE: WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.5 billion in 2009 and 5,200 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, ACQUITY, UPLC, UltraPerformance LC, Xevo, Auto-Blend Plus, Engineered Simplicity, and UNIFI are trademarks of Waters Corporation.


'/>"/>
SOURCE Waters Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Waters Corporation and UCLA to Convene Leading Life Scientists
2. A warmer future for watersports
3. Waters and DAISO Sign Marketing Agreement for Bulk Process Chromatography Media
4. Waters Ships First Units of SYNAPT G2 Mass Spectrometer
5. First ASMS Hites Award for Outstanding Research Publication Presented to Prof. Alison Ashcroft for Her Use of Waters Synapt HDMS System to Explore Protein Complexes
6. Waters Introduces New SYNAPT G2 with Greater Power, Versatility and Speed Than Any Other High-End Mass Spectrometer
7. Waters and University of Warwick Sign Research Agreement Designed to Foster Adoption of Novel MS Technologies
8. Waters Corporation Continues to Meet Todays Challenges for Improved Laboratory Operations with New Products at Pittcon 2009
9. USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System
10. XenoTech LLC Offers Drug Industry New Metabolite Profiling Services Following Acquisition of Waters Synapt HDMS System
11. Waters New ACQUITY UPLC Online Community Attracts More Than 1,200 Members in First Month
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 11, 2016   BioInformant announces the February ... Research Products, Opportunities, Tools, and Technologies – Market Size, ... The first and ... cell industry, BioInformant has more than a decade of ... market, by stem cell type. This powerful 175 page ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... a new agreement with Bankok,Thailand-based Global Stem Cells Network (GSCN) to distribute exosome ... Latin American countries, including Mexico, Costa Rica, Dominican Republic, Colombia, Argentina, Nicaragua, Panama, ...
(Date:2/10/2016)... MONTREAL , Febr. 10, 2016 /PRNewswire/ - BioAmber Inc. ... is pleased to announce that Mitsui & Co. Ltd., ... bio-based succinic acid plant, is investing an additional CDN$25 ... equity, increasing its stake from 30% to 40%.  Mitsui ... of bio-succinic acid produced in Sarnia ...
(Date:2/10/2016)... Feb. 10, 2016  The Maryland House of Delegates ... announced that University of Maryland School of Medicine Dean ... University of Maryland Medical System President and CEO ... Medallion," the highest honor given to the public by ... Dean Reece and Mr. Chrencik for their ...
Breaking Biology Technology:
(Date:2/1/2016)...  Today, the first day of American Heart Month, ... a first of its kind workplace health solution that ... the first application of Watson ... and Welltok will create a new offering that combines ... delivered on Welltok,s health optimization platform. The effort is ...
(Date:1/25/2016)... -- Glencoe Software, the world-leading supplier of image data management ... the data management solution OMERO Plus for the newly ... Photo - http://photos.prnewswire.com/prnh/20160125/325328LOGO ... Phenotypic analysis measures the characteristics and behavior of cells, ... such as health and disease, the presence or absence ...
(Date:1/20/2016)... Minn. , Jan. 20, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... 2015. MedNet,s significant achievements are the result of the ... iMedNet eClinical , it,s comprehensive, easy-to-use ... --> --> Key MedNet growth achievements ...
Breaking Biology News(10 mins):